SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Alyssa M. Morimoto, Donna Thibault Flesher, Jihong Yang, Kristen Wolslegel, Xiangdan Wang, Ann Brady, Alexander R. Abbas, Valerie Quarmby, Eric Wakshull, Bruce Richardson, Michael J. Townsend, Timothy W. Behrens, Association of endogenous anti–interferon-α autoantibodies with decreased interferon-pathway and disease activity in patients with systemic lupus erythematosus, Arthritis & Rheumatism, 2011, 63, 8
  2. 2
    Rubina Rizvi, Mehrnaz Hojjati, Interferon-α Induced Lupus in a Patient With Chronic Hepatitis C Virus, Journal of Clinical Rheumatology, 2011, 17, 3, 152

    CrossRef

  3. 3
    F. Ballanger, M.-L. Allix, M. Rimbert, M. Audrain, J.-Y. Muller, B. Dreno, Auto-immunité induite par l’interféron à faible dose dans le mélanome stade I, Annales de Dermatologie et de Vénéréologie, 2006, 133, 6-7, 543

    CrossRef

  4. 4
    S. Alazemi, M. A. Campos, Interferon-induced sarcoidosis, International Journal of Clinical Practice, 2006, 60, 2
  5. 5
    Anna-Marie Fairhurst, Amy E. Wandstrat, Edward K. Wakeland, 2006,

    CrossRef

  6. 6
    Fu-Chin Huang, Min-Hsiu Shih, Sung-Huei Tseng, Shih-Chin Lin, Ting-Tsung Chang, Tear Function Changes During Interferon and Ribavirin Treatment in Patients With Chronic Hepatitis C, Cornea, 2005, 24, 5, 561

    CrossRef

  7. 7
    Leslie E. Wilson, David Widman, Steven H. Dikman, Peter D. Gorevic, Autoimmune disease complicating antiviral therapy for hepatitis C virus infection, Seminars in Arthritis and Rheumatism, 2002, 32, 3, 163

    CrossRef

  8. 8
    F.J. Muñoz-Rodríguez, V. Andreu Solsona, J.M. Tricas Leris, J. Vilaseca Bellsolà, Lupus eritematoso sistémico inducido por interferón alfa-2b en una paciente con infección crónica por el virus de la hepatitis C, Revista Clínica Española, 2002, 202, 5, 299

    CrossRef

  9. 9
    M. Ramos-Casals, M. García-Carrasco, J. Font Franco, M. Ingelmo Morín, Manifestaciones clínicas e inmunológicas asociadas a la infección crónica por el virus de la hepatitis C, Revista Clínica Española, 2002, 202, 4, 224

    CrossRef

  10. 10
    Anuchit Chutaputti, Adverse effects and other safety aspects of the hepatitis C antivirals, Journal of Gastroenterology and Hepatology, 2000, 15,
  11. 11
    Satoru Fukuyama, Eiji Kajiwara, Norihisa Suzuki, Naoki Miyazaki, Seizoh Sadoshima, Kaoru Onoyama, Systemic lupus erythematosus after alpha-Interferon therapy for chronic hepatitis C: a case report and review of the literature, The American Journal of Gastroenterology, 2000, 95, 1, 310

    CrossRef

  12. 12
    F.L. Dumoulin, L. Leifeld, T. Sauerbruch, U. Spengler, Autoimmunity induced by interferon-α therapy for chronic viral hepatitis, Biomedicine & Pharmacotherapy, 1999, 53, 5-6, 242

    CrossRef

  13. 13
    Gideon Nesher, Rosa Ruchlemer, Alpha-interferon-induced arthritis: clinical presentation, treatment, and prevention, Seminars in Arthritis and Rheumatism, 1998, 27, 6, 360

    CrossRef

  14. 14
    Kelly Krohn, Robert Bennett, DRUG-INDUCED AUTOIMMUNE DISORDERS, Immunology and Allergy Clinics of North America, 1998, 18, 4, 897

    CrossRef

  15. 15
    Jörg Fritzsch, Jürgen Krug, Hans-Jürgen Heberling, Interferontherapie und Autoimmunität, Medizinische Klinik, 1997, 92, 5, 265

    CrossRef

  16. 16
    Takeshi Okanoue, Shinichi Sakamoto, Yoshito Itoh, Masahito Minami, Koichiro Yasui, Masafumi Sakamoto, Kenichi Nishioji, Tatsuo Katagishi, Yoshihiro Nakagawa, Hisashi Tada, Yoshihiko Sawa, Masayuki Mizuno, Keizo Kagawa, Kei Kashima, Side effects of high-dose interferon therapy for chronic hepatitis C, Journal of Hepatology, 1996, 25, 3, 283

    CrossRef

  17. 17
    Masahide Yoshikawa, Hiroshi Fukui, Tadasu Tsujii, Immunological Adverse Effects of Interferon Treatment, Clinical Immunotherapeutics, 1995, 4, 5, 361

    CrossRef